PT Sarana Meditama Metropolitan Tbk

Jakarta Stock Exchange SAME.JK

PT Sarana Meditama Metropolitan Tbk Gross Profit for the year ending December 31, 2023: USD 28.21 M

PT Sarana Meditama Metropolitan Tbk Gross Profit is USD 28.21 M for the year ending December 31, 2023, a -7.57% change year over year. Gross profit is the difference between revenue and the cost of revenue, representing the profit earned from core business operations.

PT Sarana Meditama Metropolitan Tbk Gross Profit for the year ending December 31, 2022 was USD 30.52 M, a -19.63% change year over year.
PT Sarana Meditama Metropolitan Tbk Gross Profit for the year ending December 31, 2021 was USD 37.98 M, a 133.83% change year over year.
PT Sarana Meditama Metropolitan Tbk Gross Profit for the year ending December 31, 2020 was USD 16.24 M, a 6.17% change year over year.
PT Sarana Meditama Metropolitan Tbk Gross Profit for the year ending December 31, 2019 was USD 15.30 M, a -47.84% change year over year.

Key data

Date	Gross Profit	Operating Income	EBIT	EBITDA

Jakarta Stock Exchange: SAME.JK

PT Sarana Meditama Metropolitan Tbk

CEO	Mr. Jusup Halimi
IPO Date	Jan. 25, 2013
Location	Indonesia
Headquarters	Jalan Pulomas Barat VI No. 20
Employees	2,761
Sector	Health Care
Industries Hospitals & Clinics Pharmaceuticals

Description

PT Sarana Meditama Metropolitan Tbk engages in the hospital management of EMC Hospital Pulomas in Pulomas, East Jakarta. The company was founded in 1984 and is based in Jakarta, Indonesia. PT Sarana Meditama Metropolitan Tbk is a subsidiary of PT Elang Mahkota Teknologi Tbk.

Key trends

Past 5 years